Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy

NCT00417989 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.

NCT NCT00417989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00417989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The STAR 3 Study - A Prospective, Randomized, Two-Arm Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Versus Multiple Daily Injections (MDI) in Subjects Naïve to Insulin Pump Therapy
Lead sponsor
Medtronic MiniMed, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2007
Completion date
June 30, 2010
Enrollment
485 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes